
Endometrial safety after 5 years of continuous combined transdermal estrogen and intrauterine levonorgestrel delivery for postmenopausal hormone substitution
Keywords: Intrauterine drug delivery system (IUS); Levonorgestrel; Hormone substitution therapy (HST); Endometrial suppression; Endometrial histology; Endometrial thickness